Bioxytran (BIXT) Cost of Revenue (2010 - 2018)
Bioxytran's Cost of Revenue was $8,115 in Q2 2018, down 58.2% from $19,396 a year earlier and down 46.8% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Cost of Revenue (2010 - 2018) Analysis & Trends
On a trailing twelve-month basis, Bioxytran's Cost of Revenue was $94,038 through Jun 30, 2018, up 0.3% year-over-year; for FY2017, it was $103,979, up 8.0% from FY2016.
- Cost of Revenue shows a five-year compound annual growth rate of -3.1% (FY2012 to FY2017).
- In earlier years, Cost of Revenue was $96,304 in FY2016 (-29.0%), $135,685 in FY2015 (-18.3%), $165,977 in FY2014 (-15.9%) and $197,391 in FY2013 (+61.9%).
- The Q2 2018 figure marks the lowest quarterly Cost of Revenue since Q4 2012.
- Compared with a year earlier, Cost of Revenue was higher in three of the last eight quarters, with an average decline of 8.7%.
- The best year-over-year quarter for Cost of Revenue over five years was Q1 2014 (growth of 422.0%); the worst was Q1 2015 (a decline of 73.2%).
- Per Business Quant data, BIXT's Cost of Revenue in the three quarters before Q2 2018 was $15,249 (Q1 2018), $38,785 (Q4 2017) and $31,889 (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 8,115.00 |
| Mar 31, 2018 | 15,249.00 |
| Dec 31, 2017 | 38,785.00 |
| Sep 30, 2017 | 31,889.00 |
| Jun 30, 2017 | 19,396.00 |
| Mar 31, 2017 | 13,673.00 |
| Dec 31, 2016 | 22,469.00 |
| Sep 30, 2016 | 38,200.00 |
| Jun 30, 2016 | 18,829.00 |
| Mar 31, 2016 | 16,806.00 |
| Dec 31, 2015 | 27,954.00 |
| Sep 30, 2015 | 67,792.00 |
| Jun 30, 2015 | 14,724.00 |
| Mar 31, 2015 | 14,548.00 |
| Dec 31, 2014 | 65,469.00 |
| Sep 30, 2014 | 34,309.00 |
| Jun 30, 2014 | 12,001.00 |
| Mar 31, 2014 | 54,198.00 |
| Dec 31, 2013 | 79,260.00 |
| Sep 30, 2013 | 41,181.00 |
API Access
Bioxytran Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();